1. A clean environmental week: Let the nature breathe
   Khaled Moustafa, 2017, Science of The Total Environment CrossRef
2. Emerging landscape of circular RNAs in lung cancer
   Wei Hu et al, 2018, Cancer Letters CrossRef
3. Therapeutic potential of combined BRAF/MEK blockade in BRAF-wild type preclinical tumor models
   Anais Del Curatolo et al, 2018, J Exp Clin Cancer Res CrossRef
4. Characterization of germline mutations in familial lung cancer from the Chinese population
   Madiha Kanwal et al, 2018, Gene CrossRef
5. CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non-small cell lung cancer by regulating Galectin-1-AKT/ERK1/2 signaling
   Bai-Quan Qiu et al, 2018, J Cell Physiol CrossRef
6. Cyclophilin B promotes cell proliferation, migration, invasion and angiogenesis via regulating the STAT3 pathway in non-small cell lung cancer
   Mao-rong Teng et al, 2019, Pathology - Research and Practice CrossRef
7. Alternative splicing in lung cancer
   Alice O. Coomer et al, 2019, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
8. New discoveries of mdig in the epigenetic regulation of cancers.
   Qian Zhang et al, 2019, Semin Cancer Biol CrossRef
9. Surgical Treatment of Lung Cancer
   Haley Hoy et al, 2019, Critical Care Nursing Clinics of North America CrossRef
10. Quantifying the Potential for Future Gene Therapy to Lower Lifetime Risk of Polygenic Late-Onset Diseases
    Roman Teo Oliynyk, 2019, IJMS CrossRef
11. Evaluating the Potential of Younger Cases and Older Controls Cohorts to Improve Discovery Power in Genome-Wide Association Studies of Late-Onset Diseases
    Roman Teo Oliynyk, 2019, JPM CrossRef
12. Lung Cancer Mortality in China
    Ning Wang et al, 2019, Chest CrossRef
13. Propensity score analysis of lung cancer risk in a population with high prevalence of non-smoking related lung cancer.
    Kuei-Feng Lin et al, 2017, BMC Pulm Med CrossRef
14. null
    Timothy Craig Allen, 2018 CrossRef
15. Polysaccharide-enhanced ARGET ATRP signal amplification for ultrasensitive fluorescent detection of lung cancer CYFRA 21-1 DNA
    Xia Wang et al, 2020, Anal Bioanal Chem CrossRef
16. Radon Biomonitoring and microRNA in Lung Cancer
    Rakhmet Bersimbaev et al, 2020, IJMS CrossRef
17. Clinical significance of circulating tumor cells and metabolic signatures in lung cancer after surgical removal
    Dawei Yang et al, 2020, J Transl Med CrossRef
18. MicroRNA-296, a suppressor non-coding RNA, downregulates SGLT2 expression in lung cancer
    Xiaotian Zhang et al, 2018, Int J Oncol CrossRef
19. Plk1 promotes the migration of human lung adenocarcinoma epithelial cells via STAT3 signaling
    Weijuan Yan et al, 2018, Oncol Lett CrossRef
20. Validity of an NGS‑based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital
    Wei Cao et al, 2019, Oncol Lett CrossRef
21. Association between family history of lung cancer and lung cancer risk: a systematic review and meta-analysis
    Lina Ang et al, 2020, Lung Cancer CrossRef
22. New Target Therapies in Advanced Non-Small Cell Lung Cancer: A Review of the Literature and Future Perspectives
    Ramon Andrade de Mello et al, 2020, JCM CrossRef
23. Artificial Intelligence Tools for Refining Lung Cancer Screening
    J. Luis Espinoza et al, 2020, JCM CrossRef
24. Annotation and extraction of age and temporally-related events from clinical histories
    Judy Hong et al, 2020, BMC Med Inform Decis Mak CrossRef
25. Plausible Role of Estrogens in Pathogenesis, Progression and Therapy of Lung Cancer.
    Claudia Musial et al, 2021, Int J Environ Res Public Health CrossRef
26. null
    Amir Mousapasandi et al, 2021 CrossRef
27. A label-free immunosensor for the detection of a new lung cancer biomarker, GM2 activator protein, using a phosphomolybdic acid/polyethyleneimine coated gold nanoparticle composite
    Kulrisa Kuntamung et al, 2021, Analyst CrossRef
28. Molecular pathogenesis of hereditary lung cancer: a literature review
    Souraya Rammal et al, 2021, Pharmacogenomics CrossRef
29. The Role of Family Health History in Predicting Midlife Chronic Disease Outcomes
    Naomi N. Duke et al, 2021, American Journal of Preventive Medicine CrossRef
30. Biomacromolecule-mediated pulmonary delivery of siRNA and anti-sense oligos: challenges and possible solutions
    Yaseen Hussain et al, 2021, Expert Rev. Mol. Med. CrossRef
31. Multilocus Inherited Neoplasia Allele Syndrome (MINAS): an update
    Anthony McGuigan et al, 2022, Eur J Hum Genet CrossRef
32. Lung cancer mortality trends in Mexico, 1998–2018: the impact of the General Law on Tobacco Control
    Juan Alejandro Torres-Domínguez et al, 2022, Rev. bras. epidemiol. CrossRef
33. Towards Machine Learning-Aided Lung Cancer Clinical Routines: Approaches and Open Challenges
    Francisco Silva et al, 2022, JPM CrossRef
34. Exosomes as Nanocarriers for Theragnostic miRNA Markers in Nonsmall Cell Lung Cancer Therapy
    Ziyu Jiang et al, 2022, Journal of Nanomaterials CrossRef
35. Wide Next-Generation Sequencing Characterization of Young Adults Non-Small-Cell Lung Cancer Patients
    Paola Ulivi et al, 2022, Cancers CrossRef
36. A new approach used in docking study for predicting the combination drug efficacy in EML4-ALK target of NSCLC
    Saleena Younus et al, 2022, Journal of Biomolecular Structure and Dynamics CrossRef
37. Risk Factors for Lung Cancer in the Province of Lecce: Results from the PROTOS Case–Control Study in Salento (Southern Italy)
    Fabrizio Minichilli et al, 2022, IJERPH CrossRef
38. Functional studies of lung cancer GWAS beyond association
    Erping Long et al, 2022 CrossRef
39. Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer
    Jinyoung Byun et al, 2022, Nat Genet CrossRef
40. null
    Iago Dillion Lima Cavalcanti, 2022 CrossRef
41. A mouse model of lung cancer induced via intranasal injection for anticancer drug screening and evaluation of pathology.
    Ryo Tanaka et al, 2023, FEBS Open Bio CrossRef
42. Construction and case study of a novel lung cancer risk index
    Ali Faghani et al, 2022, BMC Cancer CrossRef
43. Association of CYP19A1 rs28757157 polymorphism with lung cancer risk in the Chinese Han population
    Chan Zhang et al, 2022, World J Surg Onc CrossRef
44. Immunotherapeutics in lung cancers: from mechanistic insight to clinical implications and synergistic perspectives
    Hardeep Singh Tuli et al, 2022, Mol Biol Rep CrossRef
45. The Importance of the Immune System and Molecular Cell Signaling Pathways in the Pathogenesis and Progression of Lung Cancer
    Jolanta Smok-Kalwat et al, 2023, IJMS CrossRef
46. Label-free electrochemical detection of cancer biomarkers DNA and anti-p53 at tin oxide quantum dot-gold-DNA nanoparticle modified electrode
    Yesurajan Allwin Richard et al, 2023, Bioelectrochemistry CrossRef
47. Liquid Biopsy for Lung Cancer: Up-to-Date and Perspectives for Screening Programs
    Giovanna Maria Stanfoca Casagrande et al, 2023, IJMS CrossRef
48. Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review
    Leila Gholami et al, 2023, CMC CrossRef
49. A literature review of microRNA and gene signaling pathways involved in the apoptosis pathway of lung cancer
    Hanie Abolfathi et al, 2023, Respir Res CrossRef
50. Lung cancer immunotherapy: progress, pitfalls, and promises.
    Aritraa Lahiri et al, 2023, Mol Cancer CrossRef
51. The Role of Pembrolizumab (Keytruda) in Treating Non-small Cell Lung Cancer
    Linwei Ren, 2023, HSET CrossRef
52. Are calcium channel blockers related to lung cancer?
    Ratchanon Rattanathanoo et al, 2023, dti CrossRef
53. Lycium barbarum polysaccharide reduces lung cancer immunotherapy-related endocrine adverse reactions and improves prognosis via interleukin-2
    Zhiping Lv et al, 2023, mat express CrossRef
54. null
    Kawthar Mohamed et al, 2023 CrossRef
55. Applications of nanotechnology in the treatment of pulmonary diseases
    Rahit Kumar Dey et al, 2023, Vessel Plus CrossRef
56. null
    Koshy Alexander et al, 2023 CrossRef
57. Assessing a Polygenic Risk Score for Lung Cancer Susceptibility in Non-Hispanic White and Black Populations
    Matthew R. Trendowski et al, 2023 CrossRef
58. Insights into the Biological Activity and Cytotoxic Mechanism of Epimedium pubigerum
    Gökçe Seyhan et al, 2023, Chemistry & Biodiversity CrossRef
59. Design, synthesis and biological evaluation of small molecule fluorescent probes targeting EGFR for tumor detection and treatment
    Depu Song et al, 2023, Analyst CrossRef
60. Prevalence, patterns, and factors associated with tobacco use among patients with priority tobacco related illnesses at four Kenyan national referral hospitals, 2022
    Valerian Mwenda et al, 2023, PLOS Glob Public Health CrossRef
61. Regulation and therapeutic potentials of microRNAs to non-small cell lung cancer
    Mai Thi Le et al, 2023, Heliyon CrossRef
62. PVT1 lncRNA in Lung Cancer: A Key Player in Tumorigenesis and Therapeutic Opportunities
    Mohammed Ageeli Hakami et al, 2023, Pathology - Research and Practice CrossRef
63. In Vitro Cytotoxicity of Reproductive Stage Withania somnifera Leaf and Stem on HepG2 Cell Line
    Lali Lingfa et al, 2023, Evidence-Based Complementary and Alternative Medicine CrossRef
64. Risk factors for the development of lung cancer around the world: a review
    Hervé Agonsanou et al, 2023 CrossRef
65. null
    Koshy Alexander et al, 2024 CrossRef
66. Promises of Protein Kinase Inhibitors in Recalcitrant Small-Cell Lung Cancer: Recent Scenario and Future Possibilities
    Aniket Tiwari et al, 2024, Cancers CrossRef
67. Characterization of Incidental Pathogenic Germline Findings Detected via ctDNA among Patients with Non-Small Cell Lung Cancer in a Predominantly Hispanic/Latinx Population
    Esha Vallabhaneni et al, 2024, Cancers CrossRef
68. Dual-specificity tyrosine-regulated kinase 2 exerts anti-tumor effects by induction of G1 arrest in lung adenocarcinoma
    Eriko Harada et al, 2024, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
69. Exhaled breath condensate contains extracellular vesicles (EVs) that carry miRNA cargos of lung tissue origin that can be selectively purified and analyzed
    Megan I. Mitchell et al, 2024, J of Extracellular Vesicle CrossRef
70. Low-Dose Computed Tomography Scan and Biopsy for Assessing Lung Cancer Prevalence and Related Factors in High-Risk Populations
    Duy Hoang Tran et al, 2024, Heliyon CrossRef
71. SMAC Mimetics for the Treatment of Lung Carcinoma: Present Development and Future Prospects
    Ruchi Pandey et al, 2024, MRMC CrossRef
72. Modification Role of Dietary Antioxidants in the Association of High Red Meat Intake and Lung Cancer Risk: Evidence from a Cancer Screening Trial
    Jiaqi Yang et al, 2024, Antioxidants CrossRef
73. Pan-cancer analysis and experimental validation reveal FAM72D as a potential novel biomarker and therapeutic target in lung adenocarcinoma
    Zonglang Zhou et al, 2024, Gene CrossRef
74. Knowledge, attitude, and practice toward lung cancer risk among offspring of lung cancer patients: a cross-sectional study
    Zeru Luo et al, 2024, Sci Rep CrossRef
75. Family history of cancer and lung cancer: Utility of big data and artificial intelligence for exploring the role of genetic risk
    Virginia Calvo et al, 2024, Lung Cancer CrossRef
76. null
    Ishaan Dawar et al, 2024 CrossRef
77. Revolutionizing Lung Cancer Treatment: Nanotechnology-Driven Advances in Targeted Drug Delivery and Novel Therapeutic Strategies
    Shirin Shojaei et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
78. The Association Between Plasma Fatty Acids and Risk of Lung Cancer: A Prospective Cohort Study of the UK Biobank
    Jianv Huang et al, 2024 CrossRef
79. Advancements and Challenges in the Image-Based Diagnosis of Lung and Colon Cancer: A Comprehensive Review
    Pragati Patharia et al, 2024, Cancer Inform CrossRef
80. Genomic insights for personalised care in lung cancer and smoking cessation: motivating at-risk individuals toward evidence-based health practices
    Tony Chen et al, 2024, eBioMedicine CrossRef
81. Genetic Blueprints in Lung Cancer: Foundations for Targeted Therapies
    Andra Dan et al, 2024, Cancers CrossRef
82. Artificial Intelligence in Clinical Trials of Lung Cancer: Current and Future Prospects
    Yuhang Zhang et al, 2024, Intelligent Oncology CrossRef
83. A Comprehensive Review of Naringenin, a Promising Phytochemical with Therapeutic Potential
    Jun Hong Shin et al, 2024, J. Microbiol. Biotechnol. CrossRef
84. Association of Germline Pathogenic Variants in MUTYH and Other DNA Damage Response Genes With Lung Cancer Risk Among Non-Hispanic Whites and African Americans
    Matthew R. Trendowski et al, 2025, JCO Precis Oncol CrossRef